Search
for
Sort by
Research 871–900 of 1000+
- Nano-spanlastics-loaded dissolving microneedle patches for ketotifen fumarate: advanced strategies for allergic conjunctivitis treatment and molecular insights
- Nutrition and skin: Kids are not just little people
- Severe steroid-dependent idiopathic angioedema with response to rituximab
- Hair follicle-targeting drug delivery strategies for the management of hair follicle-associated disorders
- Screening of hair growth promoting activity of Punica granatum L. (pomegranate) leaves extracts and its potential to exhibit antidandruff and anti-lice effect
- Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients
- Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
- Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
- Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative Study
- Lichen Planopilaris and Low-Level Light Therapy: Four Case Reports and Review of the Literature About Low-Level Light Therapy and Lichenoid Dermatosis
- Modulation of T Cell Responses by Fucoidan to Inhibit Osteogenesis
- Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Non-motor Comorbidity of Myasthenia Gravis: Myasthenia Gravis as a Systemic Immunological Disorder Involving Non-motor Systems
- Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints
- Measuring Patient Quality of Life Following Treatment for Alopecia
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Depletion of <i>Gsdma1/2/3</i> alleviates PMA-induced epidermal hyperplasia by inhibiting the EGFR–Stat3/Akt pathway
- Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Immune therapies for alopecia areata: evidence and new perspectives
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- The association of medications and supplements with human male reproductive health: a systematic review
- Microneedle Transdermal Drug Delivery Systems for Allergen-Specific Immunotherapy, Skin Disease Treatment, and Vaccine Development
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Advance and Challenges in the Treatment of Skin Diseases with the Transdermal Drug Delivery System
- Microneedling combined with compound betamethasone in treatment of severe alopecia areata: A case report
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study